MELINDA LUCE: Open Payments
NPI 1245250703 · MISSOULA, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$665 in 42 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $309 · 2025 $665
Food & beverage: $565Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $233 |
| GlaxoSmithKline, LLC. | 15 | $167 |
| Janssen Biotech, Inc. | 1 | $100 |
| PFIZER INC. | 4 | $73 |
| Amgen Inc. | 2 | $29 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| UCB, Inc. | 1 | $17 |
Products named: BENLYSTA, RINVOQ, TREMFYA, SKYRIZI, XELJANZ, COSENTYX, SPEVIGO, Bimzelx.
Industry payments across MT — which companies pay providers there.
